Bovie Medical Co. (NYSE:BVX) shares saw unusually-strong trading volume on Thursday . Approximately 302,131 shares changed hands during mid-day trading, an increase of 80% from the previous session’s volume of 168,046 shares.The stock last traded at $3.80 and had previously closed at $3.56.

Several analysts have recently issued reports on BVX shares. JMP Securities reiterated an “outperform” rating and issued a $5.00 target price on shares of Bovie Medical in a research report on Wednesday, August 3rd. Zacks Investment Research upgraded shares of Bovie Medical from a “sell” rating to a “hold” rating in a research report on Wednesday, May 18th.

The firm has a 50-day moving average price of $2.32 and a 200-day moving average price of $1.93. The firm’s market cap is $102.25 million.

In other Bovie Medical news, insider John J. Mccarthy III purchased 90,750 shares of the firm’s stock in a transaction that occurred on Wednesday, August 17th. The stock was purchased at an average price of $3.30 per share, for a total transaction of $299,475.00. Following the purchase, the insider now directly owns 115,750 shares in the company, valued at $381,975. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Bovie Medical Corporation (Bovie) is an energy-based medical device company. The Company is engaged in the design, development and manufacturing of electrosurgical equipment by producing equipment for medical device manufacturers through original equipment manufacturing (OEM) agreements, as well as start-up companies.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.